SKI Market

A+| A| A-| Skip to Main Content

Indian Indices

Sensex

76,259.91 -684.37
( -0.89%)

Global Indices

Nasdaq

52,794.59 -412.31
(-0.77%)

Dow Jones

7,653.60 -53.54
(-0.69%)

Hang Seng

66,431.13 119.20
(0.18%)

Nikkei 225

10,792.77 -31.49
(-0.29%)

Forex

USD-INR

95.24 -0.24
(-0.25%)

EUR-INR

110.49 -0.08
(-0.07%)

GBP-INR

128.99 -0.20
(-0.15%)

JPY-INR

0.60 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Genpharmasec Ltd

Industry : Trading

BSE Code

ISIN Demat

Book Value()

531592

INE861N01036

1.291122

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

N.A

11.8

65.34

EPS(TTM)

Face Value()

Div & Yield %

0.1

Back

modern engineering & projects limited

Venmax Drugs & Pharmaceuticals standalone net profit rises 200.00% in the June 2026 quarter

Aug 07,2026

Net profit of Venmax Drugs & Pharmaceuticals rose 200.00% to Rs 0.12 crore in the quarter ended June 2026 as against Rs 0.04 crore during the previous quarter ended June 2025. Sales rose 104.96% to Rs 2.48 crore in the quarter ended June 2026 as against Rs 1.21 crore during the previous quarter ended June 2025.

Particulars	Quarter Ended
	Jun. 2026	Jun. 2025	% Var.
Sales	2.48	1.21	105
OPM %	4.84	3.31	-
PBDT	0.12	0.04	200
PBT	0.12	0.04	200
NP	0.12	0.04	200

76,259.91 -684.37 ( -0.89%)

52,794.59 -412.31 (-0.77%)

7,653.60 -53.54 (-0.69%)

66,431.13 119.20 (0.18%)

10,792.77 -31.49 (-0.29%)

95.24 -0.24 (-0.25%)

110.49 -0.08 (-0.07%)

128.99 -0.20 (-0.15%)

0.60 0.00 (-0.03%)